{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:02:48Z","timestamp":1793761368571,"version":"4.6.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"7952","license":[{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2023,3,16]]},"DOI":"10.1038\/s41586-023-05715-3","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T17:03:08Z","timestamp":1673888588000},"page":"482-489","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":197,"title":["Molecular fate-mapping of serum antibody responses to repeat immunization"],"prefix":"10.1038","volume":"615","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5185-364X","authenticated-orcid":false,"given":"Ari\u00ebn","family":"Schiepers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marije F. L.","family":"van \u2019t Wout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison J.","family":"Greaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinity","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1544-1493","authenticated-orcid":false,"given":"Hiromi","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo J. C.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4083-5251","authenticated-orcid":false,"given":"Ying K.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luka","family":"Mesin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler N.","family":"Starr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2368-3719","authenticated-orcid":false,"given":"Paul D.","family":"Bieniasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1008-6242","authenticated-orcid":false,"given":"Norbert","family":"Pardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1267-3408","authenticated-orcid":false,"given":"Jesse D.","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8807-348X","authenticated-orcid":false,"given":"Gabriel D.","family":"Victora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"key":"5715_CR1","first-page":"572","volume":"104","author":"T Francis","year":"1960","unstructured":"Francis, T. On the doctrine of original antigenic sin. Proc. Am. Phil. Soc. 104, 572\u2013578 (1960).","journal-title":"Proc. Am. Phil. Soc."},{"key":"5715_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1084\/jem.124.3.347","volume":"124","author":"S Fazekas de St Groth","year":"1966","unstructured":"Fazekas de St Groth, S. & Webster, R. G. Disquisitions on original antigenic sin. II. Proof in lower creatures. J. Exp. Med. 124, 347\u2013361 (1966).","journal-title":"J. Exp. Med."},{"key":"5715_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.coviro.2016.12.004","volume":"22","author":"S Cobey","year":"2017","unstructured":"Cobey, S. & Hensley, S. E. Immune history and influenza virus susceptibility. Curr. Opin. Virol. 22, 105\u2013111 (2017).","journal-title":"Curr. Opin. Virol."},{"key":"5715_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.it.2017.08.003","volume":"39","author":"C Henry","year":"2018","unstructured":"Henry, C., Palm, A. E., Krammer, F. & Wilson, P. C. From original antigenic sin to the universal influenza virus vaccine. Trends Immunol. 39, 70\u201379 (2018).","journal-title":"Trends Immunol."},{"key":"5715_CR5","doi-asserted-by":"publisher","first-page":"a038786","DOI":"10.1101\/cshperspect.a038786","volume":"11","author":"JW Yewdell","year":"2021","unstructured":"Yewdell, J. W. & Santos, J. J. S. Original antigenic sin: how original? How sinful? Cold Spring Harb. Perspect. Med. 11, a038786 (2021).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"5715_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","volume":"19","author":"F Krammer","year":"2019","unstructured":"Krammer, F. The human antibody response to influenza A virus infection and vaccination. Nat. Rev. Immunol. 19, 383\u2013397 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"5715_CR7","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.it.2021.09.001","volume":"42","author":"AK Wheatley","year":"2021","unstructured":"Wheatley, A. K. et al. Immune imprinting and SARS-CoV-2 vaccine design. Trends Immunol. 42, 956\u2013959 (2021).","journal-title":"Trends Immunol."},{"key":"5715_CR8","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1093\/infdis\/jix173","volume":"215","author":"AS Monto","year":"2017","unstructured":"Monto, A. S., Malosh, R. E., Petrie, J. G. & Martin, E. T. The doctrine of original antigenic sin: separating good from evil. J. Infect. Dis. 215, 1782\u20131788 (2017).","journal-title":"J. Infect. Dis."},{"key":"5715_CR9","doi-asserted-by":"crossref","unstructured":"Victora, G. D. & Nussenzweig, M. C. Germinal centers. Annu. Rev. Immunol. 40, 413\u2013442 (2022).","DOI":"10.1146\/annurev-immunol-120419-022408"},{"key":"5715_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-immunol-042718-041238","volume":"39","author":"N Baumgarth","year":"2021","unstructured":"Baumgarth, N. The shaping of a B cell pool maximally responsive to infections. Annu. Rev. Immunol. 39, 103\u2013129 (2021).","journal-title":"Annu. Rev. Immunol."},{"key":"5715_CR11","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.immuni.2022.05.004","volume":"55","author":"D Bhattacharya","year":"2022","unstructured":"Bhattacharya, D. Instructing durable humoral immunity for COVID-19 and other vaccinable diseases. Immunity 55, 945\u2013964 (2022).","journal-title":"Immunity"},{"key":"5715_CR12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/ni.2039","volume":"12","author":"B Pulendran","year":"2011","unstructured":"Pulendran, B. & Ahmed, R. Immunological mechanisms of vaccination. Nat. Immunol. 12, 509\u2013517 (2011).","journal-title":"Nat. Immunol."},{"key":"5715_CR13","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41586-021-03207-w","volume":"591","author":"C Gaebler","year":"2021","unstructured":"Gaebler, C. et al. Evolution of antibody immunity to SARS-CoV-2. Nature 591, 639\u2013644 (2021).","journal-title":"Nature"},{"key":"5715_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature16450","volume":"529","author":"J Tan","year":"2016","unstructured":"Tan, J. et al. A LAIR1 insertion generates broadly reactive antibodies against malaria variant antigens. Nature 529, 105\u2013109 (2016).","journal-title":"Nature"},{"key":"5715_CR15","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.cell.2019.04.036","volume":"177","author":"CW Davis","year":"2019","unstructured":"Davis, C. W. et al. Longitudinal analysis of the human B cell response to ebola virus infection. Cell 177, 1566\u20131582 (2019).","journal-title":"Cell"},{"key":"5715_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41586-021-03738-2","volume":"596","author":"JS Turner","year":"2021","unstructured":"Turner, J. S. et al. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature 596, 109\u2013113 (2021).","journal-title":"Nature"},{"key":"5715_CR17","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1038\/nm.4224","volume":"22","author":"J Lee","year":"2016","unstructured":"Lee, J. et al. Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination. Nat. Med. 22, 1456\u20131464 (2016).","journal-title":"Nat. Med."},{"key":"5715_CR18","doi-asserted-by":"publisher","first-page":"108682","DOI":"10.1016\/j.celrep.2020.108682","volume":"34","author":"J Han","year":"2021","unstructured":"Han, J. et al. Polyclonal epitope mapping reveals temporal dynamics and diversity of human antibody responses to H5N1 vaccination. Cell Rep. 34, 108682 (2021).","journal-title":"Cell Rep."},{"key":"5715_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.7326\/0003-4819-39-2-203","volume":"39","author":"T Francis Jr.","year":"1953","unstructured":"Francis, T. Jr. Influenza: the new acquayantance. Ann. Intern. Med. 39, 203\u2013221 (1953).","journal-title":"Ann. Intern. Med."},{"key":"5715_CR20","doi-asserted-by":"publisher","first-page":"e1002802","DOI":"10.1371\/journal.ppat.1002802","volume":"8","author":"J Lessler","year":"2012","unstructured":"Lessler, J. et al. Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China. PLoS Pathog. 8, e1002802 (2012).","journal-title":"PLoS Pathog."},{"key":"5715_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cell.2019.11.032","volume":"180","author":"L Mesin","year":"2020","unstructured":"Mesin, L. et al. Restricted clonality and limited germinal center reentry characterize memory B cell reactivation by boosting. Cell 180, 92\u2013106 (2020).","journal-title":"Cell"},{"key":"5715_CR22","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.cell.2020.09.063","volume":"183","author":"C Viant","year":"2020","unstructured":"Viant, C. et al. Antibody affinity shapes the choice between memory and germinal center B cell fates. Cell 183, 1298\u20131311 (2020).","journal-title":"Cell"},{"key":"5715_CR23","doi-asserted-by":"publisher","first-page":"eabn5311","DOI":"10.1126\/sciimmunol.abn5311","volume":"7","author":"M Kuraoka","year":"2022","unstructured":"Kuraoka, M. et al. Recall of B cell memory depends on relative locations of prime and boost immunization. Sci. Immunol. 7, eabn5311 (2022).","journal-title":"Sci. Immunol."},{"key":"5715_CR24","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.cell.2004.08.023","volume":"118","author":"R Mostoslavsky","year":"2004","unstructured":"Mostoslavsky, R., Alt, F. W. & Rajewsky, K. The lingering enigma of the allelic exclusion mechanism. Cell 118, 539\u2013544 (2004).","journal-title":"Cell"},{"key":"5715_CR25","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/ni.3460","volume":"17","author":"R Shinnakasu","year":"2016","unstructured":"Shinnakasu, R. et al. Regulated selection of germinal-center cells into the memory B cell compartment. Nat. Immunol. 17, 861\u2013869 (2016).","journal-title":"Nat. Immunol."},{"key":"5715_CR26","doi-asserted-by":"publisher","first-page":"14001","DOI":"10.1073\/pnas.96.24.14001","volume":"96","author":"DJ Smith","year":"1999","unstructured":"Smith, D. J., Forrest, S., Ackley, D. H. & Perelson, A. S. Variable efficacy of repeated annual influenza vaccination. Proc. Natl Acad. Sci. USA 96, 14001\u201314006 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5715_CR27","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1126\/science.1256427","volume":"346","author":"JM Fonville","year":"2014","unstructured":"Fonville, J. M. et al. Antibody landscapes after influenza virus infection or vaccination. Science 346, 996\u20131000 (2014).","journal-title":"Science"},{"key":"5715_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-med-042420-112725","volume":"73","author":"MJ Hogan","year":"2022","unstructured":"Hogan, M. J. & Pardi, N. mRNA vaccines in the COVID-19 pandemic and beyond. Annu. Rev. Med. 73, 17\u201339 (2022).","journal-title":"Annu. Rev. Med."},{"key":"5715_CR29","doi-asserted-by":"publisher","first-page":"e20201181","DOI":"10.1084\/jem.20201181","volume":"217","author":"F Schmidt","year":"2020","unstructured":"Schmidt, F. et al. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. J. Exp. Med. 217, e20201181 (2020).","journal-title":"J. Exp. Med."},{"key":"5715_CR30","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/j.immuni.2021.07.008","volume":"54","author":"F Muecksch","year":"2021","unstructured":"Muecksch, F. et al. Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations. Immunity 54, 1853\u20131868.e7 (2021).","journal-title":"Immunity"},{"key":"5715_CR31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.chom.2021.02.003","volume":"29","author":"AJ Greaney","year":"2021","unstructured":"Greaney, A. J. et al. Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell Host Microbe 29, 463\u2013476 (2021).","journal-title":"Cell Host Microbe"},{"key":"5715_CR32","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.abf9302","volume":"371","author":"TN Starr","year":"2021","unstructured":"Starr, T. N. et al. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. Science 371, 850\u2013854 (2021).","journal-title":"Science"},{"key":"5715_CR33","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41586-021-04388-0","volume":"602","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2. Nature 602, 676\u2013681 (2022).","journal-title":"Nature"},{"key":"5715_CR34","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1126\/science.abn8652","volume":"375","author":"M McCallum","year":"2022","unstructured":"McCallum, M. et al. Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement. Science 375, 864\u2013868 (2022).","journal-title":"Science"},{"key":"5715_CR35","doi-asserted-by":"crossref","unstructured":"Weisblum, Y. et al. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. eLife 9, e61312 (2020).","DOI":"10.7554\/eLife.61312"},{"key":"5715_CR36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.chom.2019.01.010","volume":"25","author":"J Lee","year":"2019","unstructured":"Lee, J. et al. Persistent antibody clonotypes dominate the serum response to influenza over multiple years and repeated vaccinations. Cell Host Microbe 25, 367\u2013376 (2019).","journal-title":"Cell Host Microbe"},{"key":"5715_CR37","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-020-2711-0","volume":"586","author":"JS Turner","year":"2020","unstructured":"Turner, J. S. et al. Human germinal centres engage memory and naive B cells after influenza vaccination. Nature 586, 127\u2013132 (2020).","journal-title":"Nature"},{"key":"5715_CR38","doi-asserted-by":"publisher","unstructured":"Alsoussi, W. B. et al. SARS-CoV-2 Omicron boosting induces de novo B cell response in humans. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2022.09.22.509040 (2022).","DOI":"10.1101\/2022.09.22.509040"},{"key":"5715_CR39","doi-asserted-by":"publisher","unstructured":"Collier, A. Y. et al. Immunogenicity of BA.5 bivalent mRNA vaccine boosters. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMc2213948 (2023).","DOI":"10.1056\/NEJMc2213948"},{"key":"5715_CR40","doi-asserted-by":"publisher","unstructured":"Wang, Q. et al. Antibody response to Omicron BA.4\u2013BA.5 bivalent booster. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMc2213907 (2023).","DOI":"10.1056\/NEJMc2213907"},{"key":"5715_CR41","doi-asserted-by":"crossref","unstructured":"Davis-Gardner, M. E. et al. Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA bivalent booster. N. Engl. J. Med. 388, 183\u2013185 (2023).","DOI":"10.1056\/NEJMc2214293"},{"key":"5715_CR42","doi-asserted-by":"publisher","unstructured":"Kurhade, C. et al. Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-022-02162-x (2022).","DOI":"10.1038\/s41591-022-02162-x"},{"key":"5715_CR43","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.chom.2020.07.001","volume":"28","author":"HA McNamara","year":"2020","unstructured":"McNamara, H. A. et al. Antibody feedback limits the expansion of B cell responses to malaria vaccination but drives diversification of the humoral response. Cell Host Microbe 28, 572\u2013585 (2020).","journal-title":"Cell Host Microbe"},{"key":"5715_CR44","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.celrep.2019.09.058","volume":"29","author":"M Meyer-Hermann","year":"2019","unstructured":"Meyer-Hermann, M. Injection of antibodies against immunodominant epitopes tunes germinal centers to generate broadly neutralizing antibodies. Cell Rep. 29, 1066\u20131073 (2019).","journal-title":"Cell Rep."},{"key":"5715_CR45","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1016\/j.immuni.2022.07.020","volume":"55","author":"JMJ Tas","year":"2022","unstructured":"Tas, J. M. J. et al. Antibodies from primary humoral responses modulate recruitment of naive B cells during secondary responses. Immunity 55, 1856\u20131871 (2022).","journal-title":"Immunity"},{"key":"5715_CR46","doi-asserted-by":"crossref","unstructured":"Schaefer-Babajew, D. et al. Antibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination. Nature 613, 735\u2013742 (2023).","DOI":"10.1038\/s41586-022-05609-w"},{"key":"5715_CR47","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3390\/vaccines9121465","volume":"9","author":"A Kok","year":"2021","unstructured":"Kok, A., Fouchier, R. A. M. & Richard, M. Cross-reactivity conferred by homologous and heterologous prime-boost A\/H5 influenza vaccination strategies in humans: a literature review. Vaccines 9, 1465 (2021).","journal-title":"Vaccines"},{"key":"5715_CR48","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1126\/science.1201730","volume":"331","author":"KA Pape","year":"2011","unstructured":"Pape, K. A., Taylor, J. J., Maul, R. W., Gearhart, P. J. & Jenkins, M. K. Different B cell populations mediate early and late memory during an endogenous immune response. Science 331, 1203\u20131207 (2011).","journal-title":"Science"},{"key":"5715_CR49","doi-asserted-by":"publisher","first-page":"13789","DOI":"10.1073\/pnas.0605944103","volume":"103","author":"E Hobeika","year":"2006","unstructured":"Hobeika, E. et al. Testing gene function early in the B cell lineage in mb1-cre mice. Proc. Natl Acad. Sci. USA 103, 13789\u201313794 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5715_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1220-4","volume":"18","author":"RM Quadros","year":"2017","unstructured":"Quadros, R. M. et al. Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins. Genome Biol. 18, 92 (2017).","journal-title":"Genome Biol."},{"key":"5715_CR51","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.immuni.2020.07.019","volume":"53","author":"D Laczko","year":"2020","unstructured":"Laczko, D. et al. A single immunization with nucleoside-modified mRNA vaccines elicits strong cellular and humoral immune responses against SARS-CoV-2 in mice. Immunity 53, 724\u2013732 (2020).","journal-title":"Immunity"},{"key":"5715_CR52","doi-asserted-by":"publisher","first-page":"7417","DOI":"10.1128\/JVI.00808-15","volume":"89","author":"PS Lee","year":"2015","unstructured":"Lee, P. S., Zhu, X., Yu, W. & Wilson, I. A. Design and structure of an engineered disulfide-stabilized influenza virus hemagglutinin trimer. J. Virol. 89, 7417\u20137420 (2015).","journal-title":"J. Virol."},{"key":"5715_CR53","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1126\/science.aad3439","volume":"351","author":"JM Tas","year":"2016","unstructured":"Tas, J. M. et al. Visualizing antibody affinity maturation in germinal centers. Science 351, 1048\u20131054 (2016).","journal-title":"Science"},{"key":"5715_CR54","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1126\/science.1086907","volume":"301","author":"H Wardemann","year":"2003","unstructured":"Wardemann, H. et al. Predominant autoantibody production by early human B cell precursors. Science 301, 1374\u20131377 (2003).","journal-title":"Science"},{"key":"5715_CR55","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.ymthe.2020.04.018","volume":"28","author":"AW Freyn","year":"2020","unstructured":"Freyn, A. W. et al. A multi-targeting, nucleoside-modified mRNA influenza virus vaccine provides broad protection in mice. Mol. Ther. 28, 1569\u20131584 (2020).","journal-title":"Mol. Ther."},{"key":"5715_CR56","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","volume":"15","author":"M Baiersdorfer","year":"2019","unstructured":"Baiersdorfer, M. et al. A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA. Mol. Ther. Nucleic Acids 15, 26\u201335 (2019).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"5715_CR57","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/mt.2013.124","volume":"21","author":"MA Maier","year":"2013","unstructured":"Maier, M. A. et al. Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics. Mol. Ther. 21, 1570\u20131578 (2013).","journal-title":"Mol. Ther."},{"key":"5715_CR58","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.immuni.2017.06.005","volume":"46","author":"J Ersching","year":"2017","unstructured":"Ersching, J. et al. Germinal center selection and affinity maturation require dynamic regulation of mTORC1 kinase. Immunity 46, 1045\u20131058 (2017).","journal-title":"Immunity"},{"key":"5715_CR59","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMc2119641","volume":"386","author":"F Schmidt","year":"2022","unstructured":"Schmidt, F. et al. Plasma neutralization of the SARS-CoV-2 Omicron variant. N. Engl. J. Med. 386, 599\u2013601 (2022).","journal-title":"N. Engl. J. Med."},{"key":"5715_CR60","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.cell.2020.08.012","volume":"182","author":"TN Starr","year":"2020","unstructured":"Starr, T. N. et al. Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding. Cell 182, 1295\u20131310 (2020).","journal-title":"Cell"},{"key":"5715_CR61","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1126\/science.abo7896","volume":"377","author":"TN Starr","year":"2022","unstructured":"Starr, T. N. et al. Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution. Science 377, 420\u2013424 (2022).","journal-title":"Science"},{"key":"5715_CR62","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.chom.2020.11.007","volume":"29","author":"AJ Greaney","year":"2021","unstructured":"Greaney, A. J. et al. Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition. Cell Host Microbe 29, 44\u201357 (2021).","journal-title":"Cell Host Microbe"},{"key":"5715_CR63","doi-asserted-by":"publisher","first-page":"e1010248","DOI":"10.1371\/journal.ppat.1010248","volume":"18","author":"AJ Greaney","year":"2022","unstructured":"Greaney, A. J. et al. A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy. PLoS Pathog. 18, e1010248 (2022).","journal-title":"PLoS Pathog."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-05715-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-05715-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-05715-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T16:07:55Z","timestamp":1679328475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-023-05715-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":63,"journal-issue":{"issue":"7952","published-print":{"date-parts":[[2023,3,16]]}},"alternative-id":["5715"],"URL":"https:\/\/doi.org\/10.1038\/s41586-023-05715-3","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,16]]},"assertion":[{"value":"29 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.P. is named on a patent (62\/153,143 \u2014\u00a0Nucleoside-modified RNA inducing an adaptive immune response), describing the use of nucleoside-modified mRNA in LNPs as a vaccine platform.\u00a0He has disclosed those interests fully to the University of Pennsylvania and has an approved plan in place for managing any potential conflicts arising from the licensing of that patent. P.J.C.L. and Y.K.T. are employees of Acuitas Therapeutics, a company that is involved in the development of mRNA\u2013LNP therapeutics. Y.K.T. is named on a\u00a0patent\u00a0(WO 2017\/004143 \u2014\u00a0Lipids and lipid nanoparticle formulations for delivery of nucleic acids)\u00a0that describes LNPs for the delivery of nucleic acid therapeutics, including mRNA, and the use of modified mRNA in lipid nanoparticles as a vaccine platform. P.D.B. has done consulting work in the area of COVID vaccines for Pfizer. J.D.B. consults or has recently consulted for Apriori Bio, Oncorus, Merck and Moderna on topics related to viruses, vaccines and viral evolution. J.D.B, T.N.S. and A.J.G. are listed as inventors on Fred Hutch licensed patents (62\/935,954 and\u00a062\/692,398)\u00a0related to viral deep mutational scanning. G.D.V. and J.D.B. are advisors for the Vaccine Company.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}